Title : Clinical outcomes in elderly patients with Morquio a syndrome receiving enzyme replacement therapy - experience in a Colombian center.

Pub. Date : 2020 Dec

PMID : 33304816






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Introduction: Mucopolysaccharidosis type IV A (MPS IVA) or Morquio A syndrome is an autosomal recessive lysosomal storage disease caused by GALNS gene mutations that lead to a deficiency of the N-acetylgalactosamine-6-sulfate sulfatase enzyme and the accumulation of two glycosaminoglycans in cell lysosomes, namely, chondroitin and keratan sulfate. Glycosaminoglycans galactosamine (N-acetyl)-6-sulfatase Homo sapiens